Prelude Therapeutics (PRLD) Stock Chart & Stock Price History → America’s worst nightmare? (From Porter & Company) (Ad) Free PRLD Stock Alerts $3.86 +0.06 (+1.58%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Prelude Therapeutics Stock Price Performance5 Day Performance-4.18%1 Month Performance-30.60%3 Month Performance+15.38%6 Month Performance+21.88%Year-To-Date Performance-8.67%1 Year Performance-42.05% Receive PRLD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. PRLD Stock Chart for Wednesday, May, 15, 2024 PRLD Chart by TradingView Prelude Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$3.73$3.80+1.88%$3.95$3.7521,629 shs$159.90 million05/10/2024$4.07$3.73-8.35%$4.04$3.6953,678 shs$156.96 million05/09/2024$3.59$4.07+13.37%$4.08$3.6252,898 shs$171.27 million05/08/2024$3.70$3.59-2.97%$3.93$3.5941,344 shs$151.07 million05/07/2024$3.83$3.70-3.39%$4.12$3.6636,872 shs$155.70 million05/06/2024$3.86$3.83-0.78%$4.06$3.8322,713 shs$161.17 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$3.99$3.86-3.26%$4.11$3.8017,251 shs$162.43 million05/02/2024$3.73$3.99+6.97%$4.02$3.7527,359 shs$167.90 million05/01/2024$3.77$3.73-1.06%$3.80$3.6522,025 shs$156.96 million04/30/2024$3.84$3.77-1.82%$3.86$3.5648,436 shs$207.05 million04/29/2024$4.07$3.84-5.65%$4.09$3.8118,176 shs$210.89 million04/26/2024$4.04$4.07+0.74%$4.07$3.9918,543 shs$223.52 million04/25/2024$3.87$4.04+4.39%$4.09$3.99115,736 shs$221.88 million04/24/2024$3.87$3.87$4.13$3.8728,584 shs$212.54 million04/23/2024$3.85$3.87+0.52%$4.07$3.8724,900 shs$212.54 million04/22/2024$3.72$3.85+3.49%$3.96$3.7550,051 shs$211.44 million04/19/2024$3.44$3.72+8.14%$3.86$3.4557,895 shs$204.30 million04/18/2024$4.18$3.44-17.70%$4.18$3.42112,889 shs$188.93 million04/17/2024$4.91$4.18-14.87%$4.92$4.1268,936 shs$229.57 million04/16/2024$5.63$4.91-12.79%$5.63$4.7938,328 shs$269.66 million04/15/2024$5.62$5.63+0.18%$5.83$5.4289,987 shs$309.20 million04/12/2024$5.22$5.62+7.66%$5.77$5.1257,997 shs$308.66 million04/11/2024$4.95$5.22+5.45%$5.35$4.8645,169 shs$286.68 million04/10/2024$4.99$4.95-0.80%$5.17$4.6724,121 shs$271.85 million04/09/2024$4.70$4.99+6.17%$5.07$4.5664,215 shs$274.05 million04/08/2024$4.70$4.70$4.82$4.6015,589 shs$258.12 million04/05/2024$4.74$4.70-0.84%$4.98$4.4717,673 shs$258.12 million04/04/2024$4.72$4.74+0.42%$4.84$4.5821,812 shs$260.32 million04/03/2024$4.62$4.72+2.16%$4.76$4.5228,329 shs$259.22 million04/02/2024$4.69$4.62-1.49%$4.65$4.4131,906 shs$253.73 million04/01/2024$4.74$4.69-1.05%$4.93$4.6114,339 shs$257.58 million03/29/2024$4.74$4.74$5.00$4.7232,074 shs$260.32 million03/28/2024$4.77$4.74-0.63%$5.00$4.7232,074 shs$260.32 million03/27/2024$4.61$4.77+3.47%$4.92$4.5633,947 shs$261.97 million03/26/2024$4.61$4.61$4.82$4.4927,359 shs$253.18 million03/25/2024$4.70$4.61-1.91%$4.92$4.5335,697 shs$253.18 million03/22/2024$4.82$4.70-2.49%$4.89$4.6428,969 shs$258.12 million03/21/2024$4.84$4.82-0.41%$4.98$4.7528,586 shs$264.71 million03/20/2024$4.84$4.84$4.94$4.7427,161 shs$265.81 million03/19/2024$4.65$4.84+4.09%$4.94$4.5448,078 shs$265.81 millionAmerica’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now.03/18/2024$4.74$4.65-1.90%$4.92$4.6145,520 shs$255.38 million03/15/2024$4.46$4.74+6.28%$4.75$4.22142,906 shs$260.32 million03/14/2024$4.62$4.46-3.46%$4.63$4.3625,124 shs$244.95 million03/13/2024$4.10$4.62+12.68%$4.66$4.1742,446 shs$253.74 million03/12/2024$4.09$4.10+0.24%$4.19$3.9244,275 shs$225.17 million03/11/2024$4.42$4.09-7.47%$4.42$4.0960,577 shs$224.62 million03/08/2024$4.38$4.42+0.91%$4.45$4.2830,060 shs$242.75 million03/07/2024$4.17$4.38+5.04%$4.45$4.1572,627 shs$240.55 million03/06/2024$4.15$4.17+0.48%$4.45$3.8849,392 shs$229.02 million03/05/2024$4.25$4.15-2.35%$4.25$4.0737,449 shs$227.92 million03/04/2024$4.59$4.25-7.41%$4.67$4.1261,276 shs$233.41 million03/01/2024$4.30$4.59+6.74%$4.63$4.0462,325 shs$252.08 million02/29/2024$4.17$4.30+3.12%$4.48$4.1375,601 shs$236.16 million02/28/2024$4.19$4.17-0.48%$4.25$4.0555,375 shs$229.02 million02/27/2024$4.09$4.19+2.44%$4.49$3.7692,427 shs$230.12 million02/26/2024$3.96$4.09+3.28%$4.19$3.9751,380 shs$224.62 million02/23/2024$3.87$3.96+2.33%$4.05$3.60157,891 shs$217.48 million02/22/2024$3.78$3.87+2.38%$3.93$3.42132,309 shs$212.54 million02/21/2024$4.16$3.78-9.13%$4.33$3.6686,720 shs$207.60 million02/20/2024$4.63$4.16-10.15%$4.56$3.85175,925 shs$228.47 million02/19/2024$4.63$4.63$4.75$3.49433,500 shs$254.28 million02/16/2024$3.48$4.63+33.05%$4.75$3.49433,292 shs$253.86 million02/15/2024$3.38$3.48+2.96%$3.68$3.37154,694 shs$190.79 million02/14/2024$3.12$3.38+8.33%$3.45$3.0963,061 shs$185.31 million02/13/2024$3.22$3.12-3.11%$3.22$3.0652,460 shs$171.07 million Related Companies: Skye Bioscience Stock Price Chart Incannex Healthcare Stock Price Chart CervoMed Stock Price Chart ProQR Therapeutics Stock Price Chart I-Mab Stock Price Chart InterCure Stock Price Chart Regulus Therapeutics Stock Price Chart Gossamer Bio Stock Price Chart Seres Therapeutics Stock Price Chart Adicet Bio Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.